Adapted Fluence Settings for Corneal Collagen Cross-linking in Mild to Moderate Progressive Keratoconus

NCT02507362 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Keratoconus

Interventions

RADIATION: adjusted corneal collagen cross-linking
RADIATION: accelerated corneal collagen cross-linking
DRUG: riboflavin 0.1% combined with dextran 20 %
PROCEDURE: epithelial debridement

Sponsor

Tehran University of Medical Sciences